UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

DYNAMICS OF SPINAL SYMPTOMS AND PHYSICAL EXERTION UNDER GLUCOCORTICOID THERAPY IN MULTIPLE SCLEROSIS (clinical-mathematical analysis)

Type of Article

In the Section

Abstract

Purpose: To evaluate the efficacy of pulse therapy and endolumbar (intrathecal) administration of glucocorticoids in patients with spinal forms of multiple sclerosis across different disease courses.

A total of 108 patients were examined, including 66 (33 with a relapsing course (RC) and 33 with progressive types of course (PTC)) who received glucocorticoid pulse therapy (GCT), and 42 patients (12 with RC and 30 with PTC) who received endolumbar administration of GCT. Age: RC — (42.3 ± 3.2) years; PTC — (50.2 ± 3.1) years; mean age at disease onset: RC — (27.9 ± 2.9) years, PTC — (32.9 ± 3.6) years; disease duration: RC — (14.1 ± 2.6) years, PTC — (17.3 ± 2.8) years.

Clinical-mathematical analysis methods: questionnaires, clinical neurological assessment, standard confidence intervals; the Wilcoxon signed-rank test for paired (pre/post) ordinal data; and McNemar’s test for binary (0/1) dichotomous variables

In RC, treatment with glucocorticoid pulse therapy promoted regression of lower-limb spastic paraparesis, marked improvement in gait, increased ability to cover longer distances, and enhanced physical activity. Endolumbar administration of GCT had positive but differentiated, patient-specific effects on the pattern of lower-limb paraparesis and tone abnormalities, and also improved gait and unassisted ambulation. At the same time, normalization of sensory disturbances, sphincter control, disappearance of pathological plantar signs, and restoration of abdominal reflexes did not reach statistical significance. In patients with PTC, under both administration regimens, the positive dynamics of neurological status involved only a slight, partial regression of neurological deficit and were selective in nature, with insufficient recovery of physical activity, especially in severe cases.

The study demonstrated that the effectiveness of pathogenetic therapy with GCT depends on the administration regimen (pulse therapy vs. endolumbar administration), disease course type, and the severity of neurological deficit. In RC, a full regression of clinical symptoms redominated regardless of regimen. In PTC — particularly in severe patients after an endolumbar course — recovery of motor, tone, and sensory disturbances was partial and selective.

Pages

References

  1. Analysis of the prevalence and incidence of multiple sclerosis in Ukraine according to official statistical reporting / [Voloshyn P.V., Voloshyna N.P., Dyachenko L.I., Levchenko I.L.] // Ukrainian Journal of Psychoneurology - Vol. 13, Issue 2 (43) - 2005.
  2. Multiple sclerosis in Ukraine: prevalence, course, prognosis, treatment, pharmacoeconomics / P.V. Voloshin, N.P. Voloshina, T.V. Negreba [et al] // Ukrainian Journal of Psychoneurology. 2007. Vol. 15, No. 1 (50). С. 6-21.
  3. Shulga O. D. Multiple sclerosis in Ukraine / O. D. Shulga, A. S. Chebanova, O. G. Kotsyuba // Ukrainian Medical Journal. 2023. No. 1(153). I/II. P. 1—4. DOI: https://doi.org/10.32471/umj.1680- 3051.153.237930
  4. Compston A. C. The pathogenesis and basis for treatment in multiple // Clin. Neurol. Neurosurg. 2004. Vol. 106, issue 3. P. 246—248. doi: https://doi.org/10.1016/j.clineuro.2004.02.007
  5. Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at  equivalent high dose  / [Alam S. M., Kyriakides T., Lawden M., Newman P. K.] // J. Neurol Neurosurg Psychiatry. 1993. № 56. Р. 1219—1220. DOI: https://doi.org/10.1136/jnnp.56.11.121
  6. Corticosteroids in the management of acute multiple sclerosis exacerbations / I. Smets, L. Van Deun, C. Bohyn [et al.] // Acta Neur Neurol Belg. 2017. Vol. 117 (3). P. 623—633. DOI: https://doi.org/10.1007/s13760-017-0772-0
  7. Comparative effectiveness of hormonal pulse therapy in recurrent and secondary progressive types of multiple sclerosis with different prognoses. Report I. The effectiveness of hormonal pulse therapy in the early stages and during the relapsing phase of relapsing and secondary progressive types of multiple sclerosis with different prognoses  / N. P. Voloshina, T. V. Negreba, V. V. Vasilovsky [et al.] // International Neurological Journal. 2018. Vol. 4 (98). P. 21–31. URL: http://www.mif-ua.com/archive/article/46247
  8. Goodin D. Glucocorticoid treatment of  multiple sclerosis // Handb. Clin. Neurol. 2014. Vol. 122. Р. 455—464. DOI: https://doi.org/10.1016/B978-0-444-52001-20020-0
  9. Voloshin PV, Voloshina NP, Taitslin VI, Leshchenko AG, Negreba TV, Negrich TI. [et al.] Sovremennyye aspekty rasseyannogo skleroza: patogenez, osobennosti techeniya v Ukraine, diagnostika, standarty patogeneticheskoy terapii [Modern aspects of multiple sclerosis: pathogenesis, features of the course in Ukraine, diagnostics, standards of pathogenetic therapy]. Neuron-Review (Journal of Clinical Neurosciences). 2007;3:4-26. (In Russian).
  10. Negreba T. V. Techeniye i prognoz sovremennykh form rasseyannogo skleroza: Svidotstvo pro reiestratsiiu avtorskoho prava na naukovyi tvir No. 30251 vid 15.09.2009. (In Russian).
  11. Prohnostychni kryterii pry riznykh typakh perebihu rozsiianoho sklerozu / N. P. Voloshyna, T. V. Nehreba, I. L. Levchenko, T. M. Tkachova, O. V. Yehorkina : Avtorske pravo na naukovyi tvir No. 39160 vid 14.07.2011 r
  12. Voloshyna N. P., Nehreba T. V., Vasylovskyi V. V., Levchenko I. L., Yehorkina O. V., Tkachova T. M., Chernenko M. Ie., Gaponov I. K. Novi pidkhody do klinichnoi diahnostyky riznykh typiv perebihu rozsiianoho sklerozu i ikh dyferentsiiovana terapiia : praktychni rekomendatsii. Svidotstvo pro reiestratsiiu avtorskoho prava na naukovyi tvir No. 47786 vid 13.02.2013 r. (In Ukrainian)
  13. Vasylovskyi VV. Prohrediientni typy perebihu rozsiianoho sklerozu: kliniko-patohenetychna kharakterystyka perebihu, prohnoz ta novi pidkhody do stratehii likuvannia [dissertation]. Kharkiv : Institute of Neurology, Psychiatry and Narcology of the NAMS of Ukraine, 2018. 200 p. (In Ukrainian)
  14. Vasylovskyy V. Тhe efficiency of glucocorticoid therapy in secondary-progressive course of multiple sclerosis // EUREKA: Health Sciences, Tallin, Etsti. 2018. No. 4. Р. 13—21. DOI: https://doi.org/10.21303/2504-5679.2018.00697
  15. Comparative effectiveness of hormone pulse therapy in relapsing and secondary progressive types of multiple sclerosis with different prognoses. Report II. The effectiveness of hormonal pulse therapy at the stage of progression in secondary progressive multiple sclerosis with different prognoses / N. P. Voloshina, T. V. Negreba, V. V. Vasilovsky et al. // International Neurological Journal. 2018. No. 7 (101). Pp. 11–16. URL: http://www.mif-ua.com/archive/article/46908
  16. Voloshyna N. P., Litovchenko T. A., Nehreba T. V., VasylovskyiV. V., V Kirzhner. M., Chernenko M. Ie., VoloshynHaponov I. K. Formuvannia kharakteru prohnozu zalezhno vid shliakhiv rozvytku etapu prohresuvannia i variantiv prohresuvannia pry prohrediientnykh typakh perebihu rozsiianoho skleroz. Ukrainskyi visnyk psykhonevrolohii [Ukrainian Bulletin of Psychoneurology]. 2021. 29, 3 (108); 18—22. https:// doi.org/10.36927/2079-0325-V29-is3-2021-3. (In Ukrainian). https://doi.org/10.36927/2079-0325-V29-is3-2021-3
  17. Voloshyna N. P. Treatment of patients with progressive multiple sclerosis using endolumbar administration of glucocorticoids / N. P. Voloshyna, V. V. Vasylovskyi, M. Ye. Chernenko: Declaratory patent of Ukraine No. 68758A 17KA 61135/00 No. 200310 9479 // Information bulletin [of the Academy of Medical Sciences of Ukraine]. Kyiv, 2006. Issue 21.
  18. Experience and effectiveness of endolumbar administration of glucocorticoids in progressive types of multiple sclerosis / N. P. Voloshina, V. V. Vasilovsky, I. L. Levchenko [et al.] // Ukrainian Neurological Journal. 2014. No. 1 (30). Pp. 68–74. URL: http://nbuv.gov.ua/UJRN/UNJ_2014_1_12
  19. Modern Experience of Pharmacotherapeutic Use and Effectiveness of Endolumbal Administration of Glucocorticoids in Progressive Types of Course for Multiple Sclerosis / V. Vasylovskyy, T. Nehreba, M. Chernenko [et al.] // SSP Modern Pharmacy and Medicine. 2024. Vol. 4. Issue 3. Р. 1—10. DOI: https://doi.org/10.53933/sspmpm.v4i3.157
  20. Application of Glucocorticoids in Therapy of Multiple Sclerosis / Vasylovskyy V., Nehreba T., Voloshyna N. [et al.] // SSP Modern Pharmacy and Medicine. 2024. Vol. Issue 2. Р. 1—14. DOI: https://doi.org/10.53933/sspmpm.v4i2.141
  21. Questionnaire "Assessment of clinical, anamnestic, and neuroimaging data in patients with multiple sclerosis before and after glucocorticoid therapy" / Voloshyna N. P., Negreba T. V., Pogulyayeva T. M. : Proceedings of the 1st International Scientific Conference "Neurology: Diagnosis and Treatment" after glucocorticoid therapy" / Voloshyna N. P., Negreba T. V., Pogulyayeva T. M.: Certificate of copyright registration for work No. 130784 dated 17.10.2024. Ukraine.
  22. Sysa AG, Zhivitskaya EP. Statisticheskiy analiz v biologii i meditsine. Minsk, 2018. 140 p. (P. 27-72). ISBN 978-985-7205- 08-0. (In Russian). http://www.statsoft.ru/home/textbook/esc.html